ヨルダンのがん患者における補完医療と代替医療の使用の傾向とパターン: 10年間の比較
Nedal Al-Rawashdeh1,2, Mohammad Alqudimat3, Ibrahim Alananzeh4
1The Office of Scientific Affairs and Research, King Hussein Cancer Center, Amman, 11941, Jordan.
BMC complementary medicine and therapies
|August 26, 2025
まとめ
2013年から2022年の間,ヨルダンのがん患者の間で補充医学と代替医療 (CAM) の使用は著しく減少しました. しかし,現在の使用者はCAMの使用頻度を増やし,患者と医療提供者とのコミュニケーションを改善する必要性を強調しました.
科学分野:
- 腫瘍学
- 統合医療
- 公衆衛生
背景:
- 補足医学および代替医学 (CAM) の使用は,世界的にがん治療において一般的です.
- ヨルダンの癌患者のCAMパターンに関するデータは限られている.
- 2013年から2022年の間,ヨルダンのCAM使用傾向を比較することで,このギャップを埋めています.
研究 の 目的:
- 2013年から2022年の間,ヨルダンでがん患者の間での 補完医療と代替医療 (CAM) の使用を比較する.
- CAMの使用における変化傾向と関連する要因を特定する.
- 臨床実務と患者教育への影響を理解する
主な方法:
- 2013年と2022年にヨルダンで成人のがん患者を対象に横断調査が行われました.
- 参加者は社会人口統計,CAMの使用,医療提供者とのコミュニケーションに関する検証されたアンケートを記入しました.
- 募集場所の違いは,2013年の4つの施設と2022年のキング・フセイン・ガンセンター (KHCC) のみです.
主要な成果:
- CAMの罹患率は2013年の49.4%から2022年の32.8%に減少した.
- 天然保健品は最も一般的なCAM療法でした.
- 罹患率が低下したにもかかわらず,毎日のCAM使用は増加し,認知された効果は著しく減少しました.
- CAMに関する医療提供者とのコミュニケーションはわずかに改善したが,依然として低い水準であった.
結論:
- ヨルダン人の癌患者の間でのCAMの使用は 10年以上にわたって減少しましたが,使用の強度は増加しました.
- 認知された利益の減少と 患者と医療提供者の間のコミュニケーションの低さは 教育的な介入の必要性を強調しています
- ターゲットを絞ったプログラムは対話を改善し,より安全なCAM統合を保証し,患者の成果を潜在的に向上させることができます.
関連する概念動画
01:21Cancer Survival Analysis
453
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
453
02:50Combination Therapies and Personalized Medicine
5.1K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K
02:49Cancer Therapies
7.9K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.9K
02:56Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
02:57Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
02:18Cancer
49.5K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
49.5K